OTC Markets OTCPK - Delayed Quote USD
Radiopharm Theranostics Limited (RDPTF)
0.0113
0.0000
(0.00%)
At close: April 28 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | 883k | 11.62M |
| Low Estimate | -- | -- | 883k | 11.62M |
| High Estimate | -- | -- | 883k | 11.62M |
| Year Ago Sales | -- | -- | 203.21k | 883k |
| Sales Growth (year/est) | -- | -- | 334.53% | 1,216.26% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RDPTF | -- | -- | -- | -- |
| S&P 500 | 9.70% | 3.97% | 8.29% | 13.85% |
Related Tickers
IUGNF Imugene Limited
0.0171
0.00%
IMU.AX Imugene Limited
0.0240
0.00%
APRE Aprea Therapeutics, Inc.
1.7400
+4.82%
RPTX Repare Therapeutics Inc.
1.3700
+3.79%
NRXP NRx Pharmaceuticals, Inc.
2.1200
+3.41%
CCCC C4 Therapeutics, Inc.
1.6400
+3.80%
ALLR Allarity Therapeutics, Inc.
1.2000
+5.26%
ARQT Arcutis Biotherapeutics, Inc.
14.91
+1.08%
HUMA Humacyte, Inc.
1.4500
+1.40%
VERV Verve Therapeutics, Inc.
5.67
+3.85%